Metformin use and the risks of herpes zoster and postherpetic neuralgia in patients with type 2 diabetes
- 14 November 2022
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 95 (1) , e28278
Abstract
Herpes zoster and postherpetic neuralgia cause substantial pain in patients. Persons with type 2 diabetes (T2D) are prone to zoster infection and postherpetic neuralgia due to compromised immunity. We conducted this study to evaluate the risks of herpes zoster and postherpetic neuralgia between metformin users and nonusers. Propensity score matching was utilized to select 47 472 pairs of metformin users and nonusers from Taiwan's National Health Insurance Research Database between January 1, 2000, and December 31, 2017. The Cox proportional hazards models were used for comparing the risks of herpes zoster and postherpetic neuralgia between metformin users and nonusers in patients with T2D. Compared with no‐use of metformin, the adjusted hazard ratios (95% confidence interval) for metformin use in herpes zoster and postherpetic neuralgia were 0.70 (0.66, 0.75) and 0.510 (0.39, 0.68), respectively. A higher cumulative dose of metformin had further lower risks of herpes zoster and postherpetic neuralgia than metformin no‐use. This nationwide cohort study demonstrated that metformin use was associated with a significantly lower risk of herpes zoster and postherpetic neuralgia than metformin no‐use. Moreover, a higher cumulative dose of metformin was associated with further lower risks of these outcomes.Keywords
Funding Information
- China Medical University Hospital
- Taipei Veterans General Hospital
This publication has 19 references indexed in Scilit:
- Metformin: historical overviewDiabetologia, 2017
- Varicella zoster virus infectionNature Reviews Disease Primers, 2015
- Metformin Inhibits Monocyte-to-Macrophage Differentiation via AMPK-Mediated Inhibition of STAT3 Activation: Potential Role in AtherosclerosisDiabetes, 2014
- Postherpetic NeuralgiaNew England Journal of Medicine, 2014
- Herpes ZosterNew England Journal of Medicine, 2013
- Chronic Illness with Complexity: Implications for Performance Measurement of Optimal Glycemic ControlJournal of General Internal Medicine, 2007
- What does epidemiology tell us about risk factors for herpes zoster?The Lancet Infectious Diseases, 2004
- Taiwan’s New National Health Insurance Program: Genesis And Experience So FarHealth Affairs, 2003
- Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control groupStatistics in Medicine, 1998
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998